More Business Wire
View Older Stories View Newer Stories-
Verde Clean Fuels, Inc. Reports 2023 Results
-
Pacific Coast Oil Trust Announces There Will Be No March Cash Distribution
-
Amerant Bancorp Inc. to Announce First Quarter 2024 Financial Results and Host Conference Call
-
Six Nuveen Closed-End Funds Announce Availability of 19(a) Notices
-
Hilton Grand Vacations Elevates Dan Mathewes to President and Chief Financial Officer, Appoints Dusty Tonkin as EVP, Chief Sales & Marketing Officer
-
World Kinect Corporation to Host First Quarter 2024 Earnings Conference Call on April 25, 2024
-
DC Secretary Announces Annual Determinations Committees Outcome
-
AM Best Removes From Under Review With Developing Implications, Affirms Credit Ratings of Certain Curi Insurance Group Members
-
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
-
Carnegie Learning Named 2024 SIIA CODiE Award Finalist for Best Educational Game and Best AI Implementation in Ed Tech
-
Cepton, Inc. Reports Fourth Quarter and Full Year 2023 Results
-
AN2 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business and Scientific Highlights
-
First Trust Enhanced Equity Income Fund Issues Notice Regarding March 2024 Distribution
-
Pulse Biosciences Announces Plans to Initiate a Rights Offering
-
First Trust Advisors L.P. Announces Distribution for Exchange-Traded Funds
-
Equity Commonwealth Announces First Quarter 2024 Earnings Conference Call
-
BT Brands Reports 2023 Results
-
Intellinetics Grows 2023 Full-Year Revenues 21%
-
Planet Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024
-
John Legend to Perform at City Year Los Angeles’ 13th Annual Spring Break Event
-
Torrid Reports Fourth Quarter and Fiscal 2023 Results and Initiates Fiscal 2024 Guidance
-
Getaround Reports Full Year 2023 Results
-
P3 Health Partners Announces Fourth Quarter and Full Year 2023 Results
-
Fastenal Releases 2024 Environmental, Social, and Governance (ESG) Report
-
Surf Air Mobility Reports Financial Results for Fourth Quarter and Full Year Ended December 31, 2023
-
Ascent Industries Reports Fourth Quarter and Full Year 2023 Results
-
Amneal to Ring the Nasdaq Closing Bell on April 2, 2024
-
Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024
-
Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Lo
-
Werner Enterprises to Announce First Quarter Earnings and Host Earnings Call on April 30, 2024
-
Domo Introduces Groundbreaking AI Features to Expand Domo.AI Framework and Bring the Transformative Power of AI to All
-
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2023 Financial Results and Business Highlights
-
Myomo Appoints Heather Getz to its Board of Directors
-
Yelp Appoints Dan Jedda to its Board of Directors as George Hu Steps Down
-
Energous Corporation Reports 2023 Results
-
National Storage Affiliates Trust Announces Promotion of Melissa Cameron to Chief Marketing Officer
-
Planet to Provide Carbon Mapper, Inc. with Hyperspectral Data Until 2030
-
Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System
-
Utz Brands, Inc. Increases Quarterly Cash Dividend
-
Sixth Street Specialty Lending, Inc. Schedules Earnings Release and Conference Call to Discuss its First Quarter Ended March 31, 2024 Financial Results
-
SOFTRAX Named 2024 SIIA CODiE Award Finalist in Best Subscription Billing Solution
-
Leafly Holdings, Inc. Announces Appointment of Two Cannabis Industry Veterans to Its Board
-
Leafly Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
-
Immunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired Assets
-
Danimer Scientific Announces Fourth Quarter and Full Year 2023 Results
-
Bristol Myers Squibb Provides Update on the First Phase 3 YELLOWSTONE Trial Evaluating Oral Zeposia (ozanimod) in Patients with Moderate to Severe Active Crohn’s Disease
-
EACO Corporation Reports Record 2nd Quarter Net Sales and Record 2nd Quarter Net Income
-
Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference
-
Eaton Vance Closed-End Funds Release Estimated Sources of Distributions
